Frontlight ResearchEarly access
Trial site
James Lind Centro De Investigacion Del Cancer
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Metastatic breast cancer5 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Liver and biliary tract cancer2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 311 trials
- Phase 1/22 trials
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Gilead Sciences4 trials
- Amgen3 trials
- Daiichi Sankyo1 trial
- Dizal Pharmaceuticals1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026